Novopharma Plus
Novopharma Plus is a Tashkent pharmaceutical producer registered in 2002, with a documented history of medicine development and manufacturing.
Registered as a joint venture in July 2002 and based in Tashkent, Novopharma Plus JV LLC is backed by substantial foreign equity investments from holding companies, including Treponiti Tower Limited and Bazar Vista Limited. Its early development program covered production facilities, equipment installation, and the creation of a testing laboratory during 2001–2004. In 2007, Novopharma Plus became the first pharmaceutical manufacturer in Uzbekistan to be certified to international Good Manufacturing Practice (GMP) standards.
The company’s products appear in Uzbekistan’s pharmaceutical registration records, including injectable formulations. This manufacturing background places it within the country’s established network of finished medicine producers. In June 2013 the company obtained quality management certification for development, manufacturing, and distribution. Its evolution reflects a combination of production infrastructure, quality systems, and foreign strategic investment required to build a modern pharmaceutical business.